PROGRESSIVE PULMONARY FIBROSIS
Clinical trials for PROGRESSIVE PULMONARY FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE PULMONARY FIBROSIS trials appear
Sign up with your email to follow new studies for PROGRESSIVE PULMONARY FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New lung fibrosis pill tested for Long-Term safety in 1,700 patients
Disease control Recruiting nowThis study tests the long-term safety of the drug nerandomilast in people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). All 1,700 participants have already taken the drug in a previous study. They will take nerandomilast tablets for up to 1 yea…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Inhaled treprostinil aims to slow lung decline in fibrosis trial
Disease control Recruiting nowThis phase 3 study tests whether an inhaled drug called treprostinil can slow the worsening of lung function in people with progressive pulmonary fibrosis, a condition where lung scarring gets worse over time. About 698 adults will receive either the drug or a placebo four times …
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New inhaled drug for lung scarring moves to Long-Term safety check
Disease control Recruiting nowThis study looks at the long-term safety of an inhaled drug (AP01) for people with progressive lung scarring (pulmonary fibrosis). It is for those who already completed an earlier Avalyn Pharma study. About 340 participants will receive the drug and be monitored for side effects …
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: PHASE2 • Sponsor: Avalyn Pharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Quercetin: a new hope for lung fibrosis?
Disease control Recruiting nowThis study tests whether quercetin, a natural compound found in many fruits and vegetables, can slow lung scarring and improve breathing in people with pulmonary fibrosis. Half of the 100 participants will take quercetin pills daily for 24 weeks, while the other half receive stan…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: NA • Sponsor: Katerina M. Antoniou • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New drug HRS-9813 aims to slow lung scarring in fibrosis patients
Disease control Recruiting nowThis study tests a new drug called HRS-9813 in 270 adults with pulmonary fibrosis (IPF or PPF), a condition where lung tissue becomes scarred and breathing gets harder. The trial compares the drug to a placebo to see if it improves lung function and is safe. Participants take the…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Streamlined lung care cuts patient travel time
Symptom relief Recruiting nowThis study aims to see if bundling all routine tests and doctor visits into one coordinated hospital trip can save time for people with interstitial lung disease. About 152 adults with the condition will either receive standard care or the new streamlined approach. The goal is to…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: NA • Sponsor: Hospital de Granollers • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
New app aims to bring palliative care to lung patients at home
Symptom relief Recruiting nowThis study tests a mobile app called SUPPORT-T that helps patients with progressive pulmonary fibrosis and their caregivers access palliative care from home. The app includes nurse-guided telehealth visits and virtual support groups over one year. Researchers want to see if the a…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New study checks muscle loss in lung patients on common meds
Knowledge-focused Recruiting nowThis pilot study looks at how anti-fibrotic medications affect body composition in people with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). Researchers will use bioelectrical impedance analysis (BIA) and muscle ultrasound to track changes in muscle…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Sponsor: Royal Brompton & Harefield NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
500-Patient study aims to unlock secrets of progressive lung scarring
Knowledge-focused Recruiting nowThis study follows 500 adults with progressive pulmonary fibrosis (a type of lung scarring) for 24 months. Researchers will collect medical images, lung function tests, and blood samples to better classify the disease and predict its course. The goal is to improve how doctors ide…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Sponsor: University of Massachusetts, Worcester • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC